Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene

M. Mark,; E.F. Adams,; A.-M. Morelli,; O. Jakobovitz-Picard,; M. Buchfelder,; R.M.W. Hofstra,; I.Μ. Mulder,; L. DeMarco,; M.L. Brandl,; E. Friedman,

doi:10.1515/IJDHD.2000.1.3.149

Startseite Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene

Artikel

Lizenziert

Nicht lizenziert Erfordert eine Authentifizierung

Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene

M. Mark, , E.F. Adams, , A.-M. Morelli, , O. Jakobovitz-Picard, , M. Buchfelder, , R.M.W. Hofstra, , I.Μ. Mulder, , L. DeMarco, , M.L. Brandl, und E. Friedman,

Veröffentlicht/Copyright: 1. Juli 2000

Veröffentlicht von

Veröffentlichen auch Sie bei De Gruyter Brill

Informationen für Autor*innen Erkunden Sie dieses Fachgebiet

Aus der Zeitschrift International Journal on Disability and Human Development Band 1 Heft 3

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Mark,, M., Adams,, E.F., Morelli,, A.-M., Jakobovitz-Picard,, O., Buchfelder,, M., Hofstra,, R.M.W., Mulder,, I.Μ., DeMarco,, L., Brandl,, M.L. and Friedman,, E.. "Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene" International Journal on Disability and Human Development, vol. 1, no. 3, pp. 149-158. https://doi.org/10.1515/IJDHD.2000.1.3.149

Mark,, M., Adams,, E., Morelli,, A., Jakobovitz-Picard,, O., Buchfelder,, M., Hofstra,, R., Mulder,, I., DeMarco,, L., Brandl,, M. & Friedman,, E. (). Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene. International Journal on Disability and Human Development, 1(3), 149-158. https://doi.org/10.1515/IJDHD.2000.1.3.149

Mark,, M., Adams,, E., Morelli,, A., Jakobovitz-Picard,, O., Buchfelder,, M., Hofstra,, R., Mulder,, I., DeMarco,, L., Brandl,, M. and Friedman,, E. () Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene. International Journal on Disability and Human Development, Vol. 1 (Issue 3), pp. 149-158. https://doi.org/10.1515/IJDHD.2000.1.3.149

Mark,, M., Adams,, E.F., Morelli,, A.-M., Jakobovitz-Picard,, O., Buchfelder,, M., Hofstra,, R.M.W., Mulder,, I.Μ., DeMarco,, L., Brandl,, M.L. and Friedman,, E.. "Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene" International Journal on Disability and Human Development 1, no. 3 (): 149-158. https://doi.org/10.1515/IJDHD.2000.1.3.149

Mark, M, Adams, E, Morelli, A, Jakobovitz-Picard, O, Buchfelder, M, Hofstra, R, Mulder, I, DeMarco, L, Brandl, M, Friedman, E. Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene. International Journal on Disability and Human Development. ;1(3): 149-158. https://doi.org/10.1515/IJDHD.2000.1.3.149

Kopie

In die Zwischenablage kopiert

BibTeX EndNote RIS

Published Online: 2000-07

Sie haben derzeit keinen Zugang zu diesem Inhalt.

Artikel in diesem Heft

CONTENTS
Letter from the Editors
Prader-Willi and Angelman Syndromes: Diagnostic Approach
Argl83His, a New Mutational "Hot-Spot" in the Growth Hormone Gene
Novel Mutation (Arg836ter) of the Sulfonylurea Receptor-1 (SUR1) Gene in Congenital Hyperinsulinism
De novo RET Mutation Positive Multiple Endocrine Neoplasia Type 2B and Hereditary Nonpolyposis Colorectal Cancer Syndrome Occurring in the Same Family: Parent-of-Origin and Mismatch Repair
Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene
Genetic Studies in Familial Aldosteronism Not Suppressible by Dexamethasone
Recombination Between the Sodium Channel SCN8A and the Allgrove Syndrome Gene in a Puerto Rican Kindred
BOOK REVIEWS. CALENDAR

Zeitschrift durchsuchen In dieser Zeitschrift suchen

https://doi.org/10.1515/IJDHD.2000.1.3.149

Artikel in diesem Heft

CONTENTS
Letter from the Editors
Prader-Willi and Angelman Syndromes: Diagnostic Approach
Argl83His, a New Mutational "Hot-Spot" in the Growth Hormone Gene
Novel Mutation (Arg836ter) of the Sulfonylurea Receptor-1 (SUR1) Gene in Congenital Hyperinsulinism
De novo RET Mutation Positive Multiple Endocrine Neoplasia Type 2B and Hereditary Nonpolyposis Colorectal Cancer Syndrome Occurring in the Same Family: Parent-of-Origin and Mismatch Repair
Bromocriptine Resistant Prolactinomas and Non-Functioning Pituitary Tumors: Somatic Mutational Analyses of the Dopamine Type 2 Receptor and the MEN1 Gene
Genetic Studies in Familial Aldosteronism Not Suppressible by Dexamethasone
Recombination Between the Sodium Channel SCN8A and the Allgrove Syndrome Gene in a Puerto Rican Kindred
BOOK REVIEWS. CALENDAR